Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Complera
| Field | Information |
|---|---|
| Medication Name | Complera |
| Generic Name | Emtricitabine / Rilpivirine / Tenofovir disoproxil fumarate |
| Boxed/Label Warning | Post-Treatment Acute Exacerbation of Hepatitis B. Severe acute exacerbations of hepatitis B (HBV) have been reported in patients who are co-infected with HBV and HIV-1 and have discontinued emtricitabine or tenofovir disoproxil fumarate, two of the components of Complera. Hepatic function should be monitored closely in these patients and, if appropriate, anti-hepatitis B treatment should be initiated. |
| Purpose | Complete HIV-1 treatment regimen |
| Mechanism of Action | Reverse transcriptase inhibitors block HIV replication |
| Dosage Forms | Oral tablets |
| Available Strengths | 200mg/25mg/300mg |
| Dosage Frequency | Once daily |
| Common Side Effects | Depression, insomnia, headache, dizziness, nausea |
| Serious Side Effects | Severe skin or hypersensitivity reactions, liver problems, kidney problems, mental health changes |
| Drug Interactions | Certain antacids, proton pump inhibitors, rifampin, certain anticonvulsants, St. John’s Wort |
| Important Notes | Take with a meal; do not use with other HIV medications unless directed by your doctor; avoid if you have severe liver or kidney problems |
| Storage | Store at room temperature away from moisture and light |
| Missed Dose | Take as soon as you remember; if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose. |
| Alternatives | Biktarvy, Triumeq, Dovato, Descovy + Darunavir/Ritonavir |
Complera Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Biktarvy | Integrase strand transfer inhibitor (INSTI)-based regimen | Single-tablet regimen containing bictegravir, emtricitabine, and tenofovir alafenamide. |
| Triumeq | Integrase strand transfer inhibitor (INSTI)-based regimen | Single-tablet regimen containing dolutegravir, abacavir, and lamivudine. Requires HLA-B*5701 testing. |
| Dovato | Integrase strand transfer inhibitor (INSTI)-based regimen | Single-tablet regimen containing dolutegravir and lamivudine. Not suitable for patients with high viral load or hepatitis B co-infection. |
| Descovy + Darunavir/Ritonavir | NRTI + Protease Inhibitor Regimen | A two-drug regimen consisting of Descovy (emtricitabine/tenofovir alafenamide) and Darunavir boosted by Ritonavir. |
Complera Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Depression | Severe skin or hypersensitivity reactions |
| Insomnia | Liver problems |
| Headache | Kidney problems |
| Dizziness | Mental health changes (e.g., suicidal thoughts) |
| Nausea | Lactic acidosis |
Complera Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| HIV-1 Infection | One tablet daily | One tablet daily | Take orally with a meal. |
Complera Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $100 |
| Without Insurance (U.S.) | $2,800 – $3,200 |
| From CPS | $ |
